Fragmenting Bulk Hydrogels and Processing into Granular Hydrogels for Biomedical Applications
May 17th, 2022
This work describes straightforward, adaptable, and low-cost methods to fabricate microgels with extrusion fragmentation, process the microgels into injectable granular hydrogels, and apply the granular hydrogels as extrusion printing inks for biomedical applications.
Overview
This work describes straightforward, adaptable, and low-cost methods to fabricate microgels with extrusion fragmentation. The microgels are processed into injectable granular hydrogels, which can be applied as extrusion printing inks for biomedical applications.
Key Study Components
Area of Science
- Biomedical engineering
- Material science
- Biomaterials
Background
- Granular hydrogels are a new class of biomaterials.
- They possess many advantageous properties for biomedical applications.
- Access to innovative methods can enhance research in this field.
- Techniques are simple and low-cost, making them accessible to various laboratories.
Purpose of Study
- To share methods for increasing access to granular hydrogels.
- To promote innovation in the use of these materials for biomedical applications.
- To provide a straightforward approach to fabricating these hydrogels.
Methods Used
- Extrusion fragmentation to fabricate microgels.
- Processing microgels into injectable granular hydrogels.
- Using granular hydrogels as extrusion printing inks.
- Implementation in various laboratory settings.
Main Results
- Demonstrated low-cost methods for hydrogel fabrication.
- Showcased adaptability to different chemistries.
- Provided a protocol for loading hydrogel precursor solutions.
- Encouraged broader access to granular hydrogels in research.
Conclusions
- Granular hydrogels can be effectively produced using simple methods.
- The techniques can facilitate biomedical applications.
- Increased accessibility may lead to further innovations in the field.
Frequently Asked Questions
Executive Industry Relevance
Granular hydrogels fabricated via extrusion fragmentation offer scalable, low-cost access to tunable biomaterials for early-stage biopharma R&D. Their injectability, microscale porosity, and adaptability to diverse chemistries position them as versatile platforms for assay development, 3D bioprinting, and advanced in vitro modeling. This method enables broader innovation and standardization in biomaterials workflows, supporting portfolio-wide translational research.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables rapid prototyping of biologically relevant matrices for mechanistic studies.
- Facilitates functional validation of cell-matrix interactions in disease-relevant systems.
- Supports predictive confidence in early-stage target assessment by providing tunable microenvironments.
Screening & Assay Development
- Provides standardized, reproducible hydrogel platforms for quantitative cell-based assays.
- Enables preparation of injectable and printable matrices for high-throughput screening formats.
- Supports assay scalability and platform reuse across compound evaluation campaigns.
Translational & Preclinical Research
- Offers adaptable hydrogel systems for in vitro modeling of tissue repair and drug delivery scenarios.
- Facilitates continuity from discovery through preclinical validation by supporting 3D culture and injectable delivery studies.
- Reduces translational risk by enabling physiologically relevant testing environments.
Pipeline & Workflow Integration
This extrusion fragmentation method integrates from early discovery through assay development and preclinical modeling, supporting iterative hypothesis testing and platform standardization.
- Discovery Biology: Accelerates hypothesis testing by enabling rapid fabrication of tunable microenvironments.
- Screening: Delivers reproducible, quantitative hydrogel matrices for robust assay outputs.
- Analytics: Supports measurement of microgel size, shape, and mechanical properties for condition comparison.
- Translational Research: Aligns with preclinical needs for injectable and 3D-printable biomaterials.
- Enterprise Reuse: Establishes a broadly adaptable platform for diverse R&D teams and applications.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in cell-matrix studies.
- Operational Value: Enables standardized, scalable, and low-cost hydrogel fabrication across teams.
- Strategic Value: Improves go/no-go decision quality and capital efficiency by supporting robust assay development.
- Portfolio Impact: Facilitates risk-adjusted prioritization and advancement of biomaterial-enabled programs.
Implementation Considerations
- Requires basic laboratory skills and standard syringes, needles, and filtration equipment.
- Needs access to UV crosslinking and microscopy for hydrogel characterization.
- Demands cross-team agreement on microgel size and mechanical property standards.
- Adaptable to a wide range of hydrogel chemistries and model systems.
- Limitations include variability in microgel shape and size inherent to fragmentation.
Biopharma FAQs
Chapters in this video
0:04
Introduction
0:33
Fabricating Bulk Hydrogels Inside of a Syringe Using Photocrosslinking
2:35
Fabricating Microgels Using Extrusion Fragmentation
5:37
Imaging Fragmented Microgels in Suspension Using Epifluorescent Microscope
6:15
Assembling Fragmented Microgels into Granular Hydrogels
7:56
Extrusion Printing with Fragmented Granular Hydrogels Inks
8:36
Results: Characterizing Fragmented Microgel Particles Using ImageJ
9:31
Conclusion
